Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians

January 5, 2018 updated by: Nicolas Senn, University of Lausanne

Study AGE - Part 2 (Active Geriatric Evaluation for General Practitioner), Performances of a Brief Assessment Tool for the Early Diagnosis of Geriatric Syndromes by Primary Care Physicians

The AGE (Active Geriatric Evaluation) aims to develop a brief assessment tool adapted to the primary care setting.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The AGE (Active Geriatric Evaluation) program is a collaborative project between a primary care institution and a specialised geriatric unit that aims to develop a brief assessment tool (BAT) adapted to the primary care setting. The objective of this study is to assess the performances of the BAT to identify major geriatric syndromes: cognitive impairment; mood disorder; functional impairment; urinary incontinence; malnutrition; gait and balance impairment; osteoporosis; hearing impairment; visual impairment.

In order to achieve our objective, we plan to recruit 155 patients > 70 years old in primary care settings for which primary care physicians will perform the BAT (composed of specific questions and clinical exams). At the end of the consultation, the primary care physician will fill a questionnaire where the absence/presence of syndromes will be recorded (according to the findings of the BAT). Each patient will be then seen a second time by expert geriatricians that will perform a full geriatric evaluation (90 minutes). This will allow to calculate the performances of the intervention (BAT) in terms of sensibility /specificity,...

Study Type

Interventional

Enrollment (Actual)

86

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
    • VD
      • Lausanne, VD, Switzerland, 1011
        • Departement of Ambulatory Care and Community Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age > 70 years
  • follow-up by general practitioner
  • good understanding of french or presence of a translater
  • No previous or on-going geriatric consultation
  • Patient able to provide consent or a relative is present that can provide a consent instead

Exclusion Criteria:

  • Age < 70 years
  • No follow-up by general practitioner
  • Unable to understand French or absence of a translater
  • On-going geriatric follow-up
  • Patient unable to provide consent or a relative is absent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: DIAGNOSTIC
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: brief assessment tool (BAT)
all participants will have a brief assessment tool (BAT) for the identification of geriatric syndromes performed by their general practitioner. Afterwards, all participants will have a full geriatric assessment performed by geriatricians
Other: brief geriatric assessment
All participants will be screened for geriatric syndromes using the brief assessment tool. Mix a simple questions and simple tests

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sensibility and specificity
Time Frame: one year
performances of the brief assessment tool (BAT) will be measured by calculating sensibility and specificity for each of the geriatric syndromes: cognitive impairment; mood disorder; functional impairment; urinary incontinence; malnutrition; gait and balance impairment; osteoporosis; hearing impairment; visual impairment
one year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Lausanne

Investigators

  • Principal Investigator: Nicolas Senn, MD PhD, Department of ambulatory care and community medicine, University of Lausanne, Switzerland

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2013

Primary Completion (ACTUAL)

November 1, 2014

Study Completion (ACTUAL)

November 1, 2014

Study Registration Dates

First Submitted

February 20, 2013

First Submitted That Met QC Criteria

March 18, 2013

First Posted (ESTIMATE)

March 21, 2013

Study Record Updates

Last Update Posted (ACTUAL)

January 9, 2018

Last Update Submitted That Met QC Criteria

January 5, 2018

Last Verified

January 1, 2018

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 287/2012

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Mood Disorders

Clinical Trials on brief geriatric assessment

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe